Big Rewards Await Pharma Companies with Big Data in the Cloud

Pharmaceutical companies aiming to leverage artificial intelligence and big data analytics without exorbitant spending should look to the cloud for their infrastructure needs.?

The plummeting costs and rising availability of genetic testing, coupled with the ubiquity of digital clinical data, are creating promising new opportunities for pharmaceutical and life sciences companies to develop innovative drugs and breakthrough precision therapies. The amount of genomic data available for research doubles in size every eight months, says Eric Banks, Senior Director of the Data Sciences and Data Engineering (DSDE) group at the Broad Institute, a collaboration between Harvard and MIT.



Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s